- Home
- Who We Are
About Us
Qu Biologics has attracted a team of life sciences professionals who are leaders in their respective fields.
- What We Do
What We Do
Qu Biologics’ SSIs restore innate immune function and reverse the chronic inflammation underlying many conditions such as cancer and immune-related disease.
- Clinical Trials
Clinical Trials
Investigational treatment QBECO SSI is an immunotherapy aimed at restoring normal immune function to reverse the chronic inflammation underlying Crohn’s disease.
- Partner With Us
Partner With Us
To gain a better understanding of the root causes of disease and the potential benefits of novel immunotherapies, Qu Biologics has a number of university research collaborations.
- Qu In The News
- Careers
Careers
Join a team of innovators who have a passion to make a difference. In a short time, our ambitious team has achieved a number of major milestones and we have many big goals ahead.
- Contact Us
Contact Page
Recent Posts
-
4 Jan 2021
Positive Signals for Endoscopic and Histologic Response in Patients with Crohn’s Disease Treated with Qu Biologics’ QBECO -
18 Dec 2020
Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu’s Novel Immunotherapy Platform -
9 Dec 2020
Qu Biologics Completes $8M Financing -
24 Aug 2020
Qu Biologics is pleased to announce the appointment of Karn Manhas to Qu’s Board of Directors
Past events:
Past events:
SBN Career Connect
November 18, 2016 @ 2:00 pm - 4:00 pmBIO 2016
June 6, 2016 - June 9, 2016Digestive Diseases Week 2016
May 21, 2016 - May 24, 2016
Search the website
GET IN TOUCH
Qu Biologics Inc.
4475 Wayburne Drive, Suite 305
Burnaby, B.C., Canada
V5G 4X4
Office: 604.734.1450 Fax: 604.676.2235
EXPLORE THE SITE
© 2020 Qu Biologics Inc. All Rights Reserved